Bio Essence Corporation
BIOE
$0.40
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 896.20K | -160.50K | -1.37M | -1.65M | -1.31M |
| Total Depreciation and Amortization | 400.00 | 600.00 | 600.00 | 800.00 | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.90K | 50.40K | 1.27M | 1.39M | 1.11M |
| Change in Net Operating Assets | 631.50K | 861.40K | 1.02M | 1.03M | 818.80K |
| Cash from Operations | 1.57M | 751.80K | 921.90K | 769.40K | 623.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00 | -100.00 | -100.00 | -100.00 |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00 | -100.00 | -100.00 | -100.00 |
| Total Debt Issued | 769.20K | 333.00K | 241.20K | 155.30K | 0.00 |
| Total Debt Repaid | -2.34M | -1.09M | -1.17M | -924.70K | -613.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -9.30K |
| Cash from Financing | -1.57M | -752.80K | -931.40K | -769.40K | -622.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.40K | -1.30K | -9.70K | -200.00 | 1.20K |